title: The effectiveness of local steroid injection after internal urethrotomy to avoid recurrence.
abstract: OBJECTIVE
  Local steroid injection to the stricture region after internal urethrotomy (IU) is a promising technique to avoid the recurrence, although the effectiveness and safety of this technique is still controversial. We aimed to determine the efficacy and safety of local steroids as applied with the IU procedure.
  
  
  METHODS
  A total of 83 patients data with urethral stricture in men were examined retrospectively. Patients classified in two groups who had steroid injection with internal urethrotomy or not. Metil prednisolone 40 mg was injected with transurethral injection needle in the stricture region at the 5, 7 and 12 o'clock sites at the same session with internal urethrotomy. Procedure was considered successful if patient did not report any voiding difficulty and maximum flow rate &gt; 15 mL/second for a voided volume of at least 150 mL after removal of the catheter. Patient's age, time to recurrence, previous recurrences were evaluated.
  
  
  RESULTS
  The mean age was 56.4 (18-83) years. Of those patients 33/83 had recurrent stenosis. Nineteen out of these 33 recurrent stenosis patients were treated with local steroid injection and 14/33 had no injection. Only two patients of the steroid treated group had recurrence. Despite that 12 patients had recurrence in the steroid non-treated group. Also the primary stenosis patients showed no recurrence at the steroid+ IU group.
  
  
  CONCLUSIONS
  The use of local steroids with IU seems to decrease the high stricture recurrence rate following IU. When local steroids were administered with complementary intention, the disease control outcomes are encouraging. Further robust comparative effectiveness studies are now required.
authors.affiliation: Department of Urology, Turgut Özal University School of Medicine, Ankara. doctorerol@yahoo.com.
authors.forename: Mehmet Erol
authors.initials: ME
authors.lastname: Yıldırım
authors.forename: Mehmet
authors.initials: M
authors.lastname: Kaynar
authors.forename: Ekrem
authors.initials: E
authors.lastname: Ozyuvali
authors.forename: Huseyin
authors.initials: H
authors.lastname: Badem
authors.forename: Muzaffer
authors.initials: M
authors.lastname: Cakmak
authors.forename: Bahadir
authors.initials: B
authors.lastname: Kosem
authors.forename: Ersin
authors.initials: E
authors.lastname: Cimentepe
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003558:Cystoscopy; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D011239:Prednisolone / Q000008:administration & dosage*; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome; D014525:Urethral Stricture / Q000175:diagnosis / Q000517:prevention & control / Q000601:surgery*
chemical_list: D005938:Glucocorticoids; D011239:Prednisolone